Pharmacokinetics of a new 200mg tablet formulation of imatinib vs 2 x 100mg commercial imatinib tablets in volunteers
Phase of Trial: Phase I
Latest Information Update: 23 Mar 2013
At a glance
- Drugs Imatinib (Primary)
- Indications Chronic myeloid leukaemia; Gastrointestinal stromal tumours
- Focus Pharmacokinetics
- 23 Mar 2013 New trial record
- 09 Mar 2013 Primary endpoint 'Peak-drug-concentration' has been met.
- 09 Mar 2013 Primary endpoint 'Area-under-the-drug-concentration-time-curve' has been met.